Miguel Malespin

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational Cohort

Miguel Malespin, A. Sidney Barritt, Stephanie Watkins et al. · Clinical Gastroenterology and Hepatology · 2021 · 68 citations · Full text

Agriculture, Nutrition, Clinical Nutrition +4

Comparison of EUS-guided versus percutaneous and transjugular approaches for the performance of liver biopsies

Asim Shuja, Ahmad Alkhasawneh, Andre Fialho et al. · Digestive and Liver Disease · 2019 · 53 citations

Medicine, Pathology, Surgery +13

Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese American Children

Miguel Malespin, Brett Sleesman, Alan H. Lau et al. · Journal of Clinical Gastroenterology · 2014 · 36 citations

Medicine, Child Health, Pediatrics +15

Barriers to treatment of chronic hepatitis C with direct acting antivirals in an urban clinic

Miguel Malespin, Ciel Harris, Ozdemir Kanar et al. · Annals of Hepatology · 2019 · 33 citations · Full text

Pharmacy, Health Sciences, Health Services Research +14